GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

ChengDu Sheng Nuo Biotec Co 688117.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

14.85

-1.07%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥741.3m

FY2017FY2025

Net income

CN¥165.8m

FY2017FY2025

Free cash flow

CN¥32.7m

FY2017FY2025

Shareholders' equity

CN¥1.06bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCN¥741.3mCN¥456.1mCN¥435.0mCN¥395.7mCN¥386.5mCN¥378.8mCN¥326.7mCN¥278.0mCN¥194.5m
Research and developmentCN¥54.9mCN¥49.2mCN¥29.0mCN¥23.3mCN¥13.7mCN¥18.2mCN¥11.1mCN¥15.7mCN¥14.5m
Operating incomeCN¥200.8mCN¥62.1mCN¥81.1mCN¥72.8mCN¥75.8mCN¥69.8mCN¥57.6mCN¥34.4mCN¥39.2m
Net incomeCN¥165.8mCN¥50.0mCN¥70.3mCN¥64.5mCN¥61.3mCN¥60.0mCN¥48.1mCN¥29.9mCN¥33.9m
Diluted earnings per share1.030.330.430.420.390.520.500.190.21

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCN¥1.93bnCN¥1.65bnCN¥1.32bnCN¥1.11bnCN¥956.6mCN¥593.0mCN¥518.9mCN¥478.3mCN¥348.2m
Cash and short-term investments—CN¥238.9mCN¥269.1mCN¥372.1mCN¥411.6mCN¥129.5mCN¥104.2mCN¥121.3mCN¥36.5m
Total liabilitiesCN¥876.9mCN¥729.6mCN¥435.6mCN¥281.3mCN¥171.5mCN¥155.4mCN¥142.5mCN¥150.9mCN¥106.5m
DebtCN¥150.2mCN¥382.2mCN¥226.8mCN¥102.6mCN¥32.9m—CN¥456,600CN¥15.4mCN¥15.0m
Shareholders' equityCN¥1.06bnCN¥918.3mCN¥879.9mCN¥826.7mCN¥785.1mCN¥437.6mCN¥376.5mCN¥327.4mCN¥241.7m
Shares outstanding161m154m164m155m157m115m97m161m161m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCN¥178.4mCN¥25.3mCN¥86.5mCN¥95.6mCN¥52.4mCN¥80.8mCN¥30.9mCN¥66.2mCN¥58.2m
Capital spending−CN¥145.8m−CN¥247.5m−CN¥278.0m−CN¥135.9m−CN¥64.2m−CN¥52.0m−CN¥30.8m−CN¥31.4m−CN¥35.1m
Free cash flowCN¥32.7m−CN¥222.2m−CN¥191.5m−CN¥40.2m−CN¥11.8mCN¥28.9mCN¥75,429CN¥34.9mCN¥23.1m
Dividends paid−CN¥36.0m−CN¥34.2m−CN¥29.2m−CN¥24.0m−CN¥25,000—−CN¥401,166−CN¥415,595−CN¥29.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥263.0mCN¥244.3mCN¥221.2mCN¥182.5mCN¥153.2mCN¥184.3mCN¥118.2mCN¥138.9m
Operating incomeCN¥87.9mCN¥86.6mCN¥53.3mCN¥43.3mCN¥47.4mCN¥56.8mCN¥540,455CN¥44.3m
Net incomeCN¥68.8mCN¥66.4mCN¥38.8mCN¥38.1mCN¥41.8mCN¥47.1m−CN¥6.9mCN¥35.2m
Diluted earnings per share0.430.410.240.240.260.29-0.050.23
Cash from operations———−CN¥21.0mCN¥72.0mCN¥8.0m——
Capital spending−CN¥22.0m−CN¥31.0m−CN¥45.0m−CN¥38.0m−CN¥16.0m−CN¥44.0m−CN¥75.0m−CN¥36.0m
Free cash flow———−CN¥59.0mCN¥56.0m−CN¥36.0m——
Total assetsCN¥2.07bnCN¥2.01bnCN¥1.93bnCN¥1.91bnCN¥1.76bnCN¥1.66bnCN¥1.65bnCN¥1.53bn
Cash and short-term investments———CN¥294.7mCN¥292.3mCN¥185.3mCN¥238.9mCN¥230.6m
DebtCN¥337.1mCN¥316.1mCN¥150.2mCN¥414.9mCN¥350.9mCN¥289.6mCN¥382.2mCN¥311.5m
Shareholders' equityCN¥1.14bnCN¥1.12bnCN¥1.06bnCN¥1.03bnCN¥993.1mCN¥966.2mCN¥918.3mCN¥918.6m

Financial ratios

Data as of 14 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2018
Operating margin25.4%16.1%20.5%19.2%18.3%18.2%—
Net margin22.4%11.0%16.2%16.3%15.8%15.8%—
Return on equity15.7%5.4%8.0%7.8%7.8%13.7%—
Return on assets8.6%3.0%5.3%5.8%6.4%10.1%—
Free cash flow yield12.5%11.1%13.9%9.3%4.6%7.2%—
Revenue growth62.6%4.8%9.9%2.4%2.0%15.9%—
Earnings growth231.5%-28.9%9.1%5.3%2.1%24.7%—
Current ratio1.41x1.32x2.53x2.96x4.01x2.32x—
Debt to equity0.14x0.42x0.26x0.12x0.04x—0.03x
Equity ratio54.7%55.7%66.9%74.6%82.1%73.8%—
Interest coverage12.42x6.12x9.83x21.28x262.94x593.87x—
R&D as a share of sales7.4%10.8%6.7%5.9%3.6%4.8%—
Buybacks as a share of market value-5.0%6.2%-6.0%1.4%-35.9%-18.9%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.3%14.4%—
Operating income40.2%23.5%—
Net income37.0%22.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings36.856.346.927.247.8
Price to sales8.26.27.64.47.6

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 17 Nov 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.0940.1020.1280.109
  • 7-for-5 split · 13 Jun 2025
  • 7-for-5 split · 19 Jun 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.